Literature DB >> 12110732

Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis.

Yoshimasa Saito1, Yae Kanai, Michiie Sakamoto, Hidetsugu Saito, Hiromasa Ishii, Setsuo Hirohashi.   

Abstract

DNA hypomethylation on pericentromeric satellite regions is an early and frequent event associated with heterochromatin instability during human hepatocarcinogenesis. A DNA methyltransferase, DNMT3b, is required for methylation on pericentromeric satellite regions during mouse development. To clarify the molecular mechanism underlying DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis, we examined mutations of the DNMT3b gene and mRNA expression levels of splice variants of DNMT3b in noncancerous liver tissues showing chronic hepatitis and cirrhosis, which are considered to be precancerous conditions, and in hepatocellular carcinomas (HCCs). Mutation of the DNMT3b gene was not found in HCCs. Overexpression of DNMT3b4, a splice variant of DNMT3b lacking conserved methyltransferase motifs IX and X, significantly correlated with DNA hypomethylation on pericentromeric satellite regions in precancerous conditions and HCCs (P = 0.0001). In particular, the ratio of expression of DNMT3b4 to that of DNMT3b3, which is the major splice variant in normal liver tissues and retains conserved methyltransferase motifs I, IV, VI, IX, and X, showed significant correlation with DNA hypomethylation (P = 0.009). Transfection of human epithelial 293 cells with DNMT3b4 cDNA induced DNA demethylation on satellite 2 in pericentromeric heterochromatin DNA. These results suggest that overexpression of DNMT3b4, which may lack DNA methyltransferase activity and compete with DNMT3b3 for targeting to pericentromeric satellite regions, results in DNA hypomethylation on these regions, even in precancerous stages, and plays a critical role in human hepatocarcinogenesis by inducing chromosomal instability.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110732      PMCID: PMC126624          DOI: 10.1073/pnas.152121799

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas.

Authors:  Y Kanai; S Ushijima; A M Hui; A Ochiai; H Tsuda; M Sakamoto; S Hirohashi
Journal:  Int J Cancer       Date:  1997-05-02       Impact factor: 7.396

2.  Tying it all together: epigenetics, genetics, cell cycle, and cancer.

Authors:  S B Baylin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

3.  Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1.

Authors:  L S Chuang; H I Ian; T W Koh; H H Ng; G Xu; B F Li
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

4.  Frequent loss in chromosome 8p loci in liver cirrhosis accompanying hepatocellular carcinoma.

Authors:  Y Kishimoto; G Shiota; K Wada; M Kitano; K Nakamoto; Y Kamisaki; T Suou; T Itoh; H Kawasaki
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

5.  Chromosomal localization of human satellites 2 and 3 by a FISH method using oligonucleotides as probes.

Authors:  I Tagarro; A M Fernández-Peralta; J J González-Aguilera
Journal:  Hum Genet       Date:  1994-04       Impact factor: 4.132

6.  De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase.

Authors:  P M Vertino; R W Yen; J Gao; S B Baylin
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

7.  Specific induction of uncoiling and recombination by azacytidine in classical satellite-containing constitutive heterochromatin.

Authors:  N Kokalj-Vokac; A Almeida; E Viegas-Péquignot; M Jeanpierre; B Malfoy; B Dutrillaux
Journal:  Cytogenet Cell Genet       Date:  1993

8.  Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas.

Authors:  K Yoshiura; Y Kanai; A Ochiai; Y Shimoyama; T Sugimura; S Hirohashi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

9.  An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome.

Authors:  M Jeanpierre; C Turleau; A Aurias; M Prieur; F Ledeist; A Fischer; E Viegas-Pequignot
Journal:  Hum Mol Genet       Date:  1993-06       Impact factor: 6.150

10.  Aberrant DNA methylation on chromosome 16 is an early event in hepatocarcinogenesis.

Authors:  Y Kanai; S Ushijima; H Tsuda; M Sakamoto; T Sugimura; S Hirohashi
Journal:  Jpn J Cancer Res       Date:  1996-12
View more
  61 in total

Review 1.  Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma.

Authors:  Igor P Pogribny; Ivan Rusyn
Journal:  Cancer Lett       Date:  2012-02-02       Impact factor: 8.679

Review 2.  Aberrant RNA splicing and its functional consequences in cancer cells.

Authors:  James D Fackenthal; Lucy A Godley
Journal:  Dis Model Mech       Date:  2008 Jul-Aug       Impact factor: 5.758

Review 3.  Molecular epigenetics and genetics in neuro-oncology.

Authors:  Raman P Nagarajan; Joseph F Costello
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

4.  Identification of a novel leukemic-specific splice variant of DNMT3B and its stability.

Authors:  Prachi Singh; Sarvagalla Sailu; Elango Palchamy; Mohane Selvaraj Coumar; Sudhakar Baluchamy
Journal:  Med Oncol       Date:  2017-07-20       Impact factor: 3.064

5.  Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma.

Authors:  Kelly R Ostler; Qiwei Yang; Timothy J Looney; Li Zhang; Aparna Vasanthakumar; Yufeng Tian; Masha Kocherginsky; Stacey L Raimondi; Jessica G DeMaio; Helen R Salwen; Song Gu; Alexandre Chlenski; Arlene Naranjo; Amy Gill; Radhika Peddinti; Bruce T Lahn; Susan L Cohn; Lucy A Godley
Journal:  Cancer Res       Date:  2012-07-18       Impact factor: 12.701

6.  Suppression of intestinal neoplasia by deletion of Dnmt3b.

Authors:  Haijiang Lin; Yasuhiro Yamada; Suzanne Nguyen; Heinz Linhart; Laurie Jackson-Grusby; Alexander Meissner; Konstantinos Meletis; Grace Lo; Rudolf Jaenisch
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

7.  Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma.

Authors:  Diego F Calvisi; Sara Ladu; Alexis Gorden; Miriam Farina; Ju-Seog Lee; Elizabeth A Conner; Insa Schroeder; Valentina M Factor; Snorri S Thorgeirsson
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

8.  Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors.

Authors:  M Ehrlich; C B Woods; M C Yu; L Dubeau; F Yang; M Campan; D J Weisenberger; Ti Long; B Youn; E S Fiala; P W Laird
Journal:  Oncogene       Date:  2006-04-27       Impact factor: 9.867

9.  Vezf1 regulates genomic DNA methylation through its effects on expression of DNA methyltransferase Dnmt3b.

Authors:  Humaira Gowher; Heidi Stuhlmann; Gary Felsenfeld
Journal:  Genes Dev       Date:  2008-08-01       Impact factor: 11.361

Review 10.  DNA methylation in hepatocellular carcinoma.

Authors:  Iris Tischoff; Andrea Tannapfe
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.